vimarsana.com
Home
Live Updates
Improving Muscle Function - Breaking News
Pages:
Improving Muscle Function News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Avidity Biosciences to Present New AOC 1001 Long-term Efficacy and Safety Data from MARINA-OLE™ Trial in People Living with Myotonic Dystrophy Type 1 (DM1) at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
John W. Day, MD, PhD, Professor of Neurology and Pediatrics, and Director, Division of Neuromuscular Medicine, Stanford University School of Medicine and a principal investigator in END-DM1,.
Stanford university
United states
San diego
Navjot rai
Geoffrey grande
Stanford university school of medicine
Division of neuromuscular medicine
Myotonic dystrophy clinical research network
Stanford university school of medicine on
Muscular dystrophy association
Avidity biosciences inc
Neuromuscular medicine
Stanford university school
Avidity biosciences
Antibody oligonucleotide conjugates
Dystrophy association
vimarsana © 2020. All Rights Reserved.